188 related articles for article (PubMed ID: 20232361)
1. Effects of transplantation of adipose tissue-derived stem cells on prostate tumor.
Lin G; Yang R; Banie L; Wang G; Ning H; Li LC; Lue TF; Lin CS
Prostate; 2010 Jul; 70(10):1066-73. PubMed ID: 20232361
[TBL] [Abstract][Full Text] [Related]
2. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
[TBL] [Abstract][Full Text] [Related]
3. CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy.
Domanska UM; Timmer-Bosscha H; Nagengast WB; Oude Munnink TH; Kruizinga RC; Ananias HJ; Kliphuis NM; Huls G; De Vries EG; de Jong IJ; Walenkamp AM
Neoplasia; 2012 Aug; 14(8):709-18. PubMed ID: 22952424
[TBL] [Abstract][Full Text] [Related]
4. Proinflammatory CXCL12-CXCR4/CXCR7 Signaling Axis Drives Myc-Induced Prostate Cancer in Obese Mice.
Saha A; Ahn S; Blando J; Su F; Kolonin MG; DiGiovanni J
Cancer Res; 2017 Sep; 77(18):5158-5168. PubMed ID: 28687617
[TBL] [Abstract][Full Text] [Related]
5. AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer.
Zhu WB; Zhao ZF; Zhou X
J Cell Physiol; 2019 Jul; 234(7):11746-11759. PubMed ID: 30537000
[TBL] [Abstract][Full Text] [Related]
6. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.
Darash-Yahana M; Pikarsky E; Abramovitch R; Zeira E; Pal B; Karplus R; Beider K; Avniel S; Kasem S; Galun E; Peled A
FASEB J; 2004 Aug; 18(11):1240-2. PubMed ID: 15180966
[TBL] [Abstract][Full Text] [Related]
7. Pigment epithelial-derived factor and melanoma differentiation associated gene-7 cytokine gene therapies delivered by adipose-derived stromal/mesenchymal stem cells are effective in reducing prostate cancer cell growth.
Zolochevska O; Yu G; Gimble JM; Figueiredo ML
Stem Cells Dev; 2012 May; 21(7):1112-23. PubMed ID: 21671747
[TBL] [Abstract][Full Text] [Related]
8. Chemokine CXCL12 and its receptor CXCR4 expression are associated with perineural invasion of prostate cancer.
Zhang S; Qi L; Li M; Zhang D; Xu S; Wang N; Sun B
J Exp Clin Cancer Res; 2008 Nov; 27(1):62. PubMed ID: 18983683
[TBL] [Abstract][Full Text] [Related]
9. Bone-derived Nestin-positive mesenchymal stem cells improve cardiac function via recruiting cardiac endothelial cells after myocardial infarction.
Lu D; Liao Y; Zhu SH; Chen QC; Xie DM; Liao JJ; Feng X; Jiang MH; He W
Stem Cell Res Ther; 2019 Apr; 10(1):127. PubMed ID: 31029167
[TBL] [Abstract][Full Text] [Related]
10. Human breast adipose-derived stem cells transfected with the stromal cell-derived factor-1 receptor CXCR4 exhibit enhanced viability in human autologous free fat grafts.
Xu FT; Li HM; Yin QS; Liu DL; Nan H; Zhao PR; Liang SW
Cell Physiol Biochem; 2014; 34(6):2091-104. PubMed ID: 25562157
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis.
Conley-LaComb MK; Semaan L; Singareddy R; Li Y; Heath EI; Kim S; Cher ML; Chinni SR
Mol Cancer; 2016 Nov; 15(1):68. PubMed ID: 27809841
[TBL] [Abstract][Full Text] [Related]
12. Effect of SDF-1/CXCR4 axis on the migration of transplanted bone mesenchymal stem cells mobilized by erythropoietin toward lesion sites following spinal cord injury.
Li J; Guo W; Xiong M; Han H; Chen J; Mao D; Tang B; Yu H; Zeng Y
Int J Mol Med; 2015 Nov; 36(5):1205-14. PubMed ID: 26398409
[TBL] [Abstract][Full Text] [Related]
13. Adipose stem cell crosstalk with chemo-residual breast cancer cells: implications for tumor recurrence.
Lyes MA; Payne S; Ferrell P; Pizzo SV; Hollenbeck ST; Bachelder RE
Breast Cancer Res Treat; 2019 Apr; 174(2):413-422. PubMed ID: 30594967
[TBL] [Abstract][Full Text] [Related]
14. Experimental study of the inhibition effect of CXCL12/CXCR4 in malignant pleural mesothelioma.
Li J; Li T; Li S; Xie L; Yang YL; Lin Q; Kadoch O; Li H; Hou S; Xu Z
J Investig Med; 2019 Feb; 67(2):338-345. PubMed ID: 30367010
[TBL] [Abstract][Full Text] [Related]
15. Combination of vessel-targeting agents and fractionated radiation therapy: the role of the SDF-1/CXCR4 pathway.
Chen FH; Fu SY; Yang YC; Wang CC; Chiang CS; Hong JH
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):777-84. PubMed ID: 23601898
[TBL] [Abstract][Full Text] [Related]
16. Injection of basic fibroblast growth factor together with adipose-derived stem cell transplantation: improved cardiac remodeling and function in myocardial infarction.
Wang B; Ma X; Zhao L; Zhou X; Ma Y; Sun H; Yang Y; Chen B
Clin Exp Med; 2016 Nov; 16(4):539-550. PubMed ID: 26349680
[TBL] [Abstract][Full Text] [Related]
17. CXCR4 antagonist delivery on decellularized skin scaffold facilitates impaired wound healing in diabetic mice by increasing expression of SDF-1 and enhancing migration of CXCR4-positive cells.
Liu H; Liu H; Deng X; Chen M; Han X; Yan W; Wang N
Wound Repair Regen; 2017 Aug; 25(4):652-664. PubMed ID: 28783870
[TBL] [Abstract][Full Text] [Related]
18. Danshensu accelerates angiogenesis after myocardial infarction in rats and promotes the functions of endothelial progenitor cells through SDF-1α/CXCR4 axis.
Yin Y; Duan J; Guo C; Wei G; Wang Y; Guan Y; Mu F; Yao M; Xi M; Wen A
Eur J Pharmacol; 2017 Nov; 814():274-282. PubMed ID: 28864209
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.
Kioi M; Vogel H; Schultz G; Hoffman RM; Harsh GR; Brown JM
J Clin Invest; 2010 Mar; 120(3):694-705. PubMed ID: 20179352
[TBL] [Abstract][Full Text] [Related]
20. Tissue-resident stem cells promote breast cancer growth and metastasis.
Muehlberg FL; Song YH; Krohn A; Pinilla SP; Droll LH; Leng X; Seidensticker M; Ricke J; Altman AM; Devarajan E; Liu W; Arlinghaus RB; Alt EU
Carcinogenesis; 2009 Apr; 30(4):589-97. PubMed ID: 19181699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
